Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Effectiveness and safety of connected solutions among people with type 2 diabetes uncontrolled on oral anti-diabetic drugs
 
  • Details
Options

Effectiveness and safety of connected solutions among people with type 2 diabetes uncontrolled on oral anti-diabetic drugs

Other Title
A randomized real-world study on Insultrate
Journal
Primary Care Diabetes
Date Issued
2026-01-01
Author(s)
YI-SUN YANG  
DOI
10.1016/j.pcd.2026.04.012
URI
https://www.scopus.com/pages/publications/105037579634
https://scholars.csmu.edu.tw/handle/123456789/32525
Abstract
Aim To evaluate the effectiveness and safety of Insultrate, a physician-configured basal insulin (BI) titration module (tool) integrated within the Health2Sync (H2S) mobile application, as a digital intervention to reduce titration inertia among people with type 2 diabetes (T2D). Methods An open-label, randomized, parallel-group, multicenter study (NCT05684341) was conducted in Taiwan (February 2023 to June 2024). It involved people with uncontrolled T2D despite their existing insulin regimens who were insulin-naïve or using BI. The primary effectiveness endpoint was change in baseline glycated hemoglobin (HbA1c) level at Week 24. Results Two hundred participants were randomized (1:1) to Insultrate or Usual-care groups; 191 were included in the intent-to-treat (ITT) analysis (Insultrate: n = 93; Usual-care: n = 98). No significant difference in insulin adherence rate was observed between the two groups at Week 24, but Insultrate showed significantly greater reductions in HbA1c (−0.87 ± 1.20% vs. −0.43 ± 1.20%; p = 0.0109) and fasting self-monitoring blood glucose levels (−56.4 ± 62.4 mg/dL vs. −45.1 ± 54.7 mg/dL; p = 0.0258). No deaths, severe adverse events, or hypoglycemia-related hospitalizations were reported. Total treatment satisfaction was numerically higher in the Insultrate group than in the Usual-care group (2.4 ± 5.90 vs. 2.2 ± 6.81, p = 0.2143). Conclusions Insultrate demonstrated favourable effectiveness and safety profiles and improved patient treatment satisfaction in this T2D population.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback